BioRestorative Therapies Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $19.600K Miss $520.000K Estimate

BioRestorative Therapies (NASDAQ: BRTX) reported a Q4 EPS of $(0.32), missing the analyst estimate of $(0.30) by 4.92%. This represents a 60% increase in losses compared to $(0.20) per share from the same period last year. The company's quarterly sales were $19.600K, falling short of the $520.000K estimate by 96.23%, and reflecting a 54.73% decrease from $43.300K in the prior year.